Cambridge’s out-of-town science hope

The Cambridge market doesn’t like to shout about its successes in property development, but the city is quietly growing into one of Europe’s most important centres for biomedical research. British-Swedish pharmaceutical company AstraZeneca signed a game-changing prelet for 800,000 sq